Cannabis 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022 November 8, 2022
Cannabis IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market November 8, 2022
Cannabis Emerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of Arrangement November 8, 2022
Cannabis New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation November 8, 2022
Cannabis Akerna to Announce Financial Results for the Third Quarter of 2022 on November 14, 2022 November 7, 2022
Cannabis High Fusion and Its Psychedelics Subsidiary Neural Therapeutics Enter into Arrangement Agreement November 5, 2022
Search
Cannabis
November 8, 2022
November 8, 2022
November 8, 2022
November 8, 2022
November 8, 2022
November 8, 2022
November 8, 2022
November 7, 2022
November 7, 2022
November 5, 2022
